alexa
Reach Us +1-504-608-239
Editor - Aparna Jayachandran | Olivia Newton-John Cancer Researc | 18228
ISSN: 2577-0535

Journal of Cancer Clinical Trials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Aparna Jayachandran

Aparna Jayachandran
Aparna Jayachandran
Research officer
Liver Cancer Unit
Gallipoli Medical Research Institute
Greenslopes Clinical School
The university of Queensland
Australia

Biography

Dr. Aparna Jayachandran’s expertise is in the research areas of cancer biology, epithelial-to-mesenchymal transition (EMT), cancer stem cells, and organ fibrosis. She obtained a PhD with Summa cum laude in Molecular Biology from the University of Giessen, Germany. During her PhD training, Dr Jayachandran successfully identified the role of TGF-beta signal transduction in EMT and its relevance to disease models of organ fibrosis. During her postdoctoral training at the Ludwig Institute for Cancer Research, Melbourne, Australia, Dr Jayachandran has extended her knowledge on EMT process in tumor biology and gained new insights into embryonic development. Her research investigated whether melanoma cells can hijack the developmental EMT process to boost their motility. Her research has yielded new insights into determinants of the EMT process in melanoma progression and metastasis. In 2015, Dr Jayachandran has joined the Gallipoli Medical Research Institute & University of Queensland, Brisbane, Australia and is investigating the association between EMT, immune evasion and cancer stem cells so as to identify and develop druggable targets in liver cancer.

Research Interest

Tumor biology, Metastasis

Global Speakers in the subject

Global Experts in the subject

Publications

Epithelial-to-Mesenchymal Transition as a Potential Target for Antineoplastic Therapies

Sushma R Rao and Aparna Jayachandran
Editorial: J Cancer Clin Trials 2016, 1:e103
Relevant Topics
Top